PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinoma

Background. The outcome of patients with adenocarcinoma of the esophagogastric junction (AEG) remains poor. The programmed cell-death-protein-1 (PD-1), a co-inhibitory receptor primarily expressed by T-cells, represents a potential new therapeutic target. PD-1, PD-1 ligand 1 (PD-L1), and PD-L2 expre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Kollmann, Dagmar, Ignatova, Desislava, Jedamzik, Julia, Chang, Yun-Tsan, Jomrich, Gerd, Baierl, Andreas, Kazakov, Dmitry, Michal, Michal, French, Lars E., Hoetzenecker, Wolfram, Schatton, Tobias, Asari, Reza, Preusser, Matthias, Gnant, Michael, Guenova, Emmanuella, Schoppmann, Sebastian F.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5980377/
https://ncbi.nlm.nih.gov/pubmed/29872575
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1435226
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados